Harmony Biosciences Holdings (HRMY) Change in Inventory (2019 - 2026)
Harmony Biosciences Holdings recorded quarterly Change in Inventory of -$76000.0 in Q1 2026, up 95.02% quarter-over-quarter from -$1.5 million in Q4 2025, and up 90.66% year-over-year from -$39860.8 in Q1 2025.
Harmony Biosciences Holdings' Change in Inventory history runs 8 years deep, the most recent figure standing at -$76000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 90.66% year-over-year to -$76000.0; the TTM figure through Mar 2026 stood at -$1.1 million (down 309.3% YoY), while the FY2025 annual figure was -$1.8 million, down 200.33% from the prior year.
- Change in Inventory came in at -$76000.0 for Q1 2026 at Harmony Biosciences Holdings, up from -$1.5 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.3 million in Q3 2024 to a low of -$1.5 million in Q4 2025.
- A 5-year average of $49941.2 and a median of $165000.0 in 2022 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory jumped 445.92% in 2024 and sank 638.87% in 2025, its largest moves.
- Harmony Biosciences Holdings' Change in Inventory stood at $397000.0 in 2022, then sank by 30.48% to $276000.0 in 2023, then grew by 2.54% to $283000.0 in 2024, then tumbled by 638.87% to -$1.5 million in 2025, then surged by 95.02% to -$76000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$76000.0, -$1.5 million, and $782000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | -76,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76,000.00 |
| Mar 31, 2026 | -76,000.00 |
| Dec 31, 2025 | -1.53 Mn |
| Dec 31, 2025 | -1.53 Mn |
| Sep 30, 2025 | 782,000.00 |
| Sep 30, 2025 | 782,000.00 |
| Jun 30, 2025 | -284,000.00 |
| Jun 30, 2025 | -284,000.00 |
| Mar 31, 2025 | -814,000.00 |
| Mar 31, 2025 | -814,000.00 |
| Dec 31, 2024 | 283,000.00 |
| Dec 31, 2024 | 283,000.00 |
| Sep 30, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | -214,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Mar 31, 2024 | 494,000.00 |
| Mar 31, 2024 | 494,000.00 |
| Dec 31, 2023 | 276,000.00 |
| Dec 31, 2023 | 276,000.00 |
| Sep 30, 2023 | 233,000.00 |
| Sep 30, 2023 | 233,000.00 |
| Jun 30, 2023 | 764,000.00 |
| Jun 30, 2023 | 764,000.00 |
| Mar 31, 2023 | -207,000.00 |
| Mar 31, 2023 | -207,000.00 |
| Dec 31, 2022 | 397,000.00 |
| Dec 31, 2022 | 397,000.00 |
| Sep 30, 2022 | -308,000.00 |
| Sep 30, 2022 | -308,000.00 |
| Jun 30, 2022 | -389,000.00 |
| Jun 30, 2022 | -389,000.00 |
| Mar 31, 2022 | 165,000.00 |
| Mar 31, 2022 | 165,000.00 |
| Dec 31, 2021 | -373,000.00 |
| Dec 31, 2021 | -373,000.00 |
| Sep 30, 2021 | -146,000.00 |
| Sep 30, 2021 | -146,000.00 |
| Jun 30, 2021 | 546,000.00 |
| Jun 30, 2021 | 546,000.00 |
| Mar 31, 2021 | 582,000.00 |
| Mar 31, 2021 | 582,000.00 |
| Dec 31, 2020 | 1.51 Mn |
| Dec 31, 2020 | 1.51 Mn |
| Sep 30, 2020 | 228,000.00 |
| Sep 30, 2020 | 228,000.00 |
| Jun 30, 2020 | 212,000.00 |
| Jun 30, 2020 | 212,000.00 |
| Mar 31, 2020 | 783,000.00 |
| Mar 31, 2020 | 783,000.00 |
| Dec 31, 2019 | 172,000.00 |
| Dec 31, 2019 | 172,000.00 |